Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 28   Next >
 
1.  
Follow-up for clinically localized renal neoplasms: AUA guideline. 2013 Apr. NGC:009917
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
2.  
ACR Appropriateness Criteria® non-invasive clinical staging of bronchogenic carcinoma. 1995 (revised 2013). NGC:010163
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
3.  
ACR–ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. 1996 (revised 2010). NGC:008422
American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s)
4.  
Lymphoma. 2012 Sep (revised 2013 Apr). NGC:010256
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Influenza immunization for adult and pediatric patients undergoing cancer treatment. 2012 Oct (revised 2013 Oct). NGC:010255
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). 2011 May (revised 2013 Aug). NGC:010000
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
7.  
8.  
Prostate cancer. 2011 Jan (revised 2013 Sep). NGC:010265
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Guidelines on muscle-invasive and metastatic bladder cancer. 2008 Mar (revised 2013 Mar). NGC:009826
European Association of Urology - Medical Specialty Society. View all guidelines by the developer(s)
10.  
ACR Appropriateness Criteria® screening for pulmonary metastases. 1995 (revised 2013). NGC:010164
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
11.  
ACR Appropriateness Criteria® renal cell carcinoma staging. 1995 (revised 2011). NGC:008871
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
12.  
The role of IMRT in gastrointestinal cancers. 2010 Oct 29. NGC:008826
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Guidelines for treatment of autoimmune neuromuscular transmission disorders. 2006 Jul (revised 2010 Jul). NGC:007905
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
14.  
ACR Appropriateness Criteria® thyroid carcinoma. 2013. NGC:010177
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Immunizations. 2007 Oct (revised 2012 Mar). NGC:009028
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
16.  
ACR Appropriateness Criteria® pretreatment staging of invasive bladder cancer. 1995 (revised 2012). NGC:009670
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
17.  
Optimal chemotherapy for recurrent ovarian cancer. 2001 Sep 21 (revised 2011 Nov 21). NGC:009858
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. 1998 (revised 2011). NGC:008460
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
20.  
1-20 of 28   Next >